A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors

NCT03787953 · clinicaltrials.gov ↗

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Anti-PD-1/PD-L1 antibodies

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]